Company Filing History:
2 out of 1,371 
1 out of 384 
Years Active: 2019-2020
Title: Jeppe Kari: Innovator in Cellobiohydrolase Variants
Introduction
Jeppe Kari is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of cellobiohydrolase variants. With a total of two patents to his name, Kari's work has implications for various applications in the industry.
Latest Patents
Kari's latest patents focus on cellobiohydrolase variants and the polynucleotides encoding them. The present invention relates to these variants, which are crucial for various biotechnological processes. Additionally, the patents cover nucleic acid constructs, vectors, and host cells that comprise the polynucleotides, along with methods for utilizing these variants effectively.
Career Highlights
Throughout his career, Jeppe Kari has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novozymes, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to innovative projects.
Collaborations
Some of his notable coworkers include Kim Borch and Kenneth Jensen. Their collaboration has likely enhanced the research and development efforts in which Kari has been involved.
Conclusion
Jeppe Kari's contributions to the field of biotechnology, particularly through his patents on cellobiohydrolase variants, highlight his role as an innovator. His work continues to influence advancements in the industry.